The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria

Current Opinion in Infectious Diseases

Volumn 28, Issue 4, 2015, Pages 375-383

  Perez, Federico ^a   Villegas, Maria Virginia ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

Author keywords

antibiotic resistance; developing countries; one health; public health agencies; surveillance

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BIOINFORMATICS; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; EUROPE; GENOTYPE; HEALTH CARE FACILITY; HUMAN; INFECTION CONTROL; ISRAEL; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; QUALITY CONTROL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; INCIDENCE; MICROBIOLOGY; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; EUROPE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 84937917218     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000182     Document Type: Review

References (45)

1. Baker S. Infectious disease. A return to the preantimicrobial era Science 2015; 347:1064-1066.
2. Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. N Engl J Med 2013; 368:299-302.
3. Grundmann H, Klugman KP, Walsh T, et al. A framework for global surveillance of antibiotic resistance. Drug Resist Updat 2011; 14:79-87.
4. WHO. Antimicrobial Resistance: Global Report on Surveillance; April 2014. 257 pp.
5. O'Brien TF, Stelling J. Integrated multilevel surveillance of the world's infecting microbes and their resistance to antimicrobial agents. Clin Microbiol Rev 2011; 24:281-295.
6. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2013 Stockholm: ECDC; 2014. Available from: http://www.ecdc.europa.eu/en/publications/-layouts/forms/Publication-DispForm. aspxList=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1205.
7. Weist K, Diaz Hogberg L. ECDC publishes 2013 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe. Euro Surveill 2014; 19: pii20962. Available from: http://www.eurosurveillance. org/ViewArticle.aspxArticleId=20962.
8. European Centre for Disease Prevention and Control. Surveillance of Antimicrobial Consumption in Europe, 2012. Stockholm: ECDC; 2014.
9. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals 2011-12. Stockholm: ECDC; 2013.
10. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of healthcare-associated infections. N Engl J Med 2014; 370:1198-1208.
11. European Society for Clinical Microbiology and Infectious Disease. European Committee on Antimicrobial Susceptibility Testing EUCAST.
12. ECDC (European Centre for Disease Prevention and Control). ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food producing animals. Stockholm/Parma/London: ECDC/EFSA/EMA; 2015.
13. Bielicki JA, Lundin R, Sharland M. Antibiotic resistance prevalence in routine bloodstream isolates from children's hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J 2015. [Epub ahead of print]
14. Navon-Venezia S, Leavitt A, Schwaber MJ, et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009; 53:818-820.
15. Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 2014; 58:697-703.
16. Ben-David D, Masarwa S, Adler A, et al. A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli postacute care hospitals. Infect Control Hosp Epidemiol 2014; 35:802-809.
17. Adler A, Hussein O, Ben-David D, et al. Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in postacute-care hospitals in Israel, 2008-13. J Antimicrob Chemother 2015; 70:89-92.
18. Centers for Disease Control and Prevention. 2013 National and State Healthcare-Associated Infections Progress Report; January 2015.
19. Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013; 34:1-14.
20. Centers for Disease Control and Prevention. Technical information-multi-site gram-negative bacilli surveillance initiative (MuGSI). 2014; Available from: http://www.cdc.gov/hai/eip/mugsi-techinfo.html. [Accessed March 25, 2015]
21. Karlowsky JA, Kelly LJ, Thornsberry C, et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network. Int J Antimicrob Agents 2002; 19:21-31.
22. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013; 62:165-170.
23. Centers for Disease Control and Prevention. Carbapenem-resistant Enterobacteriaceae in healthcare settings. Available from: http://www.cdc.gov/HAI/organisms/cre/. [Accessed March 25, 2015]
24. Johnson JK, Wilson LE, Zhao L, et al. Point prevalence of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in Maryland. Infect Control Hosp Epidemiol 2014; 35:443-445.
25. Pfeiffer CD, Cunningham MC, Poissant T, et al. Establishment of a statewide network for carbapenem-resistant Enterobacteriaceae prevention in a lowincidence region. Infect Control Hosp Epidemiol 2014; 35:356-361.
26. Brennan BM, Coyle JR, Marchaim D, et al. Statewide surveillance of carbapenem-resistant Enterobacteriaceae in Michigan. Infect Control Hospital Epidemiol 2014; 35:342-349.
27. Shaw KM, Harper JE, Vagnone PS, Lynfield R. Establishing surveillance for carbapenem-resistant Enterobacteriaceae in Minnesota, 2012. Infection Control Hospital Epidemiol 2014; 35:451-453. Description of surveillance efforts in Minnesota since the first detection of CRE in 2009.
28. van Duin D, Perez F, Rudin SD, et al. Surveillance of carbapenemresistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother 2014; 58: 4035-4041.
29. Wright MS, Perez F, Brinkac L, et al. Population structure of KPC-producing Klebsiella pneumoniae isolates from midwestern U.S. hospitals. Antimicrob Agents Chemother 2014; 58:4961-4965.
30. Lin MY, Lyles-Banks RD, Lolans K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2013; 57:1246-1252.
31. Thaden JT, Lewis SS, Hazen KC, et al. Rising rates of carbapenem-resistant Enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hospital Epidemiol 2014; 35:978-983.
32. Pfeiffer CD, Beldavs ZG. Much to do about carbapenem-resistant Enterobacteriaceae: why supplementing surveillance may be the key to stopping spread. Infect Control Hosp Epidemiol 2014; 35:984-985.
33. Lesho EP, Waterman PE, Chukwuma U, et al. The antimicrobial resistance monitoring and research (ARMoR) program: the US Department of Defense response to escalating antimicrobial resistance. Clin Infect Dis 2014; 59: 390-397.
34. National Action Plan for Combating Antibiotic-Resistant Bacteria. 2015 [cited April 26, 2015]; Available from: https://www.whitehouse.gov/sites/default/files/docs/national-action-plan-for-combating-antibotic-resistant-bacteria. Pdf
35. Nguyen KV, Thi Do NT, Chandna A, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Vietnam. BMC Public Health 2013; 13:1158.
36. Wertheim HF, Chandna A, Vu PD, et al. Providing impetus, tools, and guidance to strengthen national capacity for antimicrobial stewardship in Viet Nam. PLoS Med 2013; 10:e1001429.
37. Shallcross LJ, Davies SC. The World Health Assembly resolution on antimicrobial resistance. J Antimicrob Chemother 2014; 69:2883-2885.
38. Hernandez-Gomez C, Blanco VM, Motoa G, et al. Evolution of antimicrobial resistance in gram negative bacilli from intensive care units in Colombia. Biomedica 2014; 34 (Suppl 1):91-100.
39. Cuzon G, Naas T, Truong H, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 2010; 16:1349-1356.
40. Cuzon G, Naas T, Villegas MV, et al. Wide dissemination of Pseudomonas aeruginosa producing beta-lactamase blaKPC-2 gene in Colombia. Antimicrob Agents Chemother 2011; 55:5350-5353.
41. Guzman-Blanco M, Labarca JA, Villegas MV, Gotuzzo E. Extended spectrum beta-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis 2014; 18:421-433.
42. Teodoro D, Pasche E, Gobeill J, et al. Building a transnational biosurveillance network using semantic web technologies: requirements, design, and preliminary evaluation. J Med Internet Res 2012; 14:e73.
43. Brandt C, Makarewicz O, Fischer T, et al. The bigger picture: the history of antibiotics and antimicrobial resistance displayed by scientometric data. Int J Antimicrob Agents 2014; 44:424-430.
44. Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012; 4:148-16.
45. Conlan S, Thomas PJ, Deming C, et al. Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med 2014; 6:254ra126.